Quent Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.2K Buy
308
+1
+0.3% +$219 ﹤0.01% 689
2026
Q1
$58K Sell
307
-40
-12% -$6.99K ﹤0.01% 696
2025
Q4
$59K Buy
347
+11
+3% +$1.69K ﹤0.01% 706
2025
Q3
$44.3K Buy
+336
New +$40.3K ﹤0.01% 636
2025
Q2
Sell
-339
Closed -$42.1K 778
2025
Q1
$42.1K Buy
339
+123
+57% +$16K ﹤0.01% 596
2024
Q4
$26.6K Hold
216
﹤0.01% 734
2024
Q3
$24.1K Sell
216
-25
-10% -$2.74K ﹤0.01% 841
2024
Q2
$25.7K Sell
241
-40
-14% -$4.4K ﹤0.01% 791
2024
Q1
$33.8K Buy
281
+9
+3% +$1.1K ﹤0.01% 748
2023
Q4
$33.5K Buy
272
+29
+12% +$3.62K ﹤0.01% 718
2023
Q3
$31.5K Buy
243
+5
+2% +$666 ﹤0.01% 695
2023
Q2
$29.5K Hold
238
﹤0.01% 710
2023
Q1
$34.8K Hold
238
0.01% 675
2022
Q4
$37.9K Sell
238
-44
-16% -$6.45K 0.01% 643
2022
Q3
$38K Buy
282
+10
+4% +$1.52K 0.01% 617
2022
Q2
$42K Sell
272
-30
-10% -$4.62K 0.01% 555
2022
Q1
$47K Buy
302
+60
+25% +$8.71K 0.01% 616
2021
Q4
$31K Buy
+242
New +$31.8K 0.01% 642

Other funds holding JAZZ

Quent Capital's JAZZ Position: Q2 2026 in Review

Quent Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 0.33% in Q2 2026, buying an estimated $219 and bringing the position to 308 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Quent Capital first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Quent Capital held 308 shares of Jazz Pharmaceuticals worth $74.2K as of Q2 2026.
  • Quent Capital bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
  • Jazz Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #689 holding.
  • Quent Capital first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.